MedPath

Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio

Completed
Conditions
Hypertension in Pregnancy
Registration Number
NCT06403722
Lead Sponsor
Saint Thomas Hospital, Panama
Brief Summary

Retrospective cohort study that evaluated 190 subjects admitted with diagnosis of hypertensive disorder of pregnancy, between 24 and 36 6/7 weeks, with an sFlt-1/PlGF index greater than or equal to 110. Data were collected on their clinical course prior to termination of pregnancy, using the last reported sFlt-1/PlGF ratio value to classify the population into four cohorts: values between 110-205, between 206 and 654, between 655 and 999 and greater than 1000.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
190
Inclusion Criteria
  • Diagnosis of hypertensive disorder of pregnancy
  • Gestational age between 24 - 36 6/7
  • sFlt-1/PlGF > 110
Exclusion Criteria
  • Gestational age below 23 6/7 weeks and above 37 weeks at the moment of admission.
  • Absence of sFLt-1/PlGF ratio result.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hepatic enzyme abnormalitiesFrom the moment of admission up until discharge after delivery, average 5 to 10 days

Increase of liver enzyme to \> twice the upper limit of normal

Kidney injuryFrom the moment of admission up until discharge after delivery, average 5 to 10 days

Creatinine level \> 1.1 Doubling of creatinine levels when others causes had been excluded

Growth restricted fetusFrom the moment of admission up until delivery, average 5 to 10 days

Fetal weight below 10th percentile and abnormal doppler Fetal weight below 3th percentile

HELLP SyndromeFrom the moment of admission up until discharge after delivery, average 5 to 10 days

Elevated liver enzymes Thrombocytopenia Hemolysis

StillbirthFrom the moment of admission up until discharge after delivery, average 5 to 10 days

Intrauterine fetal demise

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saint Thomas H

🇵🇦

Panama, Panama

Saint Thomas H
🇵🇦Panama, Panama

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.